DMP evaluation reports
The Federal Joint Comitee (G-BA) as well as the authorising health insurance companies have published the first evaluation report on the indication COPD 2019.
The Federal Joint Comitee (G-BA) as well as the authorising health insurance companies have published the second evaluation reports on the two indications diabetes mellitus type 1 (DM1) 2018 and coronary heart disease (CHD) 2018. Here you can find the links to the pdf-files hosted by the G-BA.
The Federal Joint Comitee (G-BA) as well as the authorising health insurance companies have published the second evaluation reports on the two indications diabetes mellitus type 1 (DM1) 2018 and coronary heart disease (CHD) 2018. Here are the links to the pdf-files hosted by the G-BA.
The Federal Joint Comitee (G-BA) as well as the authorising health insurance companies have published the evaluation report on the DMP indication diabetes mellitus type 2 (DM2) 2017. Here is the link to the pdf-file hosted by the G-BA.
The Federal Joint Comitee (G-BA) as well as the authorising health insurance companies have published the evaluation reports on the two indications diabetes mellitus type 1 (DM1) 2016 and coronary heart disease (CHD) 2016. Here are the links to the pdf-files hosted by the G-BA.